American Century Companies Inc. Buys 32,213 Shares of Teladoc Health, Inc. (NYSE:TDOC)

American Century Companies Inc. raised its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 18.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 209,718 shares of the health services provider’s stock after purchasing an additional 32,213 shares during the period. American Century Companies Inc.’s holdings in Teladoc Health were worth $1,906,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of TDOC. Nisa Investment Advisors LLC boosted its position in shares of Teladoc Health by 20,936.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock worth $3,874,000 after acquiring an additional 424,180 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in Teladoc Health by 18.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider’s stock worth $22,213,000 after acquiring an additional 384,528 shares during the last quarter. Wealthfront Advisers LLC purchased a new stake in shares of Teladoc Health during the 4th quarter worth approximately $3,364,000. Allspring Global Investments Holdings LLC purchased a new stake in shares of Teladoc Health during the 4th quarter worth approximately $2,859,000. Finally, TCW Group Inc. bought a new position in shares of Teladoc Health during the 3rd quarter valued at approximately $2,464,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Trading Down 1.6 %

NYSE TDOC opened at $7.11 on Wednesday. Teladoc Health, Inc. has a one year low of $6.61 and a one year high of $15.21. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The company has a market capitalization of $1.24 billion, a price-to-earnings ratio of -1.23 and a beta of 1.73. The company’s 50-day simple moving average is $9.94 and its two-hundred day simple moving average is $9.73.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The business had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Equities analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Insider Transactions at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the transaction, the insider now owns 64,308 shares of the company’s stock, valued at $541,473.36. The trade was a 14.62 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.95% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on TDOC shares. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Bank of America boosted their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a report on Wednesday, February 12th. The Goldman Sachs Group decreased their target price on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Monday, March 3rd. Oppenheimer dropped their price target on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th. Finally, Royal Bank of Canada upped their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Eleven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, Teladoc Health has an average rating of “Hold” and an average price target of $11.26.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.